UB
Therapeutic Areas
Pentabase Pipeline
| Drug | Indication | Phase |
|---|---|---|
| EpiDirect® MGMT | Glioblastoma (MGMT promoter methylation) | Approved |
| PlentiPlex™ MYD88 | Waldenström's Macroglobulinemia (MYD88 L265P mutation) | Approved |
| MicroSight® MSI | Microsatellite Instability (Various Cancers) | Commercial |
| EpiDirect® MLH1 | Colorectal & Other Cancers (MLH1 methylation) | Commercial |
| Liquid Biopsy Assay Development | Various Cancers (e.g., KRAS, EGFR, BRAF mutations) | Research/Development |